Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) LT-Debt-to-Total-Asset : 0.02 (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Wanbangde Pharmaceutical Holding Group Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.02.

Wanbangde Pharmaceutical Holding Group Co's long-term debt to total assets ratio declined from Mar. 2023 (0.03) to Mar. 2024 (0.02). It may suggest that Wanbangde Pharmaceutical Holding Group Co is progressively becoming less dependent on debt to grow their business.

Wanbangde Pharmaceutical Holding Group Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co LT-Debt-to-Total-Asset Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.11

0.13

0.05

0.04

0.02

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.03	0.03	0.02	0.02

Wanbangde Pharmaceutical Holding Group Co LT-Debt-to-Total-Asset Calculation

Wanbangde Pharmaceutical Holding Group Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	93.494	/	4296.358
	=	0.02

Wanbangde Pharmaceutical Holding Group Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	66.576	/	4406.6
	=	0.02

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Wanbangde Pharmaceutical Holding Group Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008

Website

http://www.wepon.com.cn

Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.

Executives

Zhao Shou Ming	Directors, executives
Wang Tian Fang	Director
Li Rong Fang	Supervisors
Zhu Jian Xin	Directors, executives
Yang Jin Rong	Executives
Song Tie He	Directors, executives
Song Jian Hua	Executives
Pan Yun Chu	Director
Yu Ju Ming	Executives
Yang Mei Gen	Executives
Tao Jian Feng	Supervisors
Qian Shu Sheng	Executives
Shen Bai Ming	Director
Xu Yin Sheng	Director
Shuang Zhi Wei	Executives

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Headlines

No Headlines